Anti-FCN2/ EBP-37/ FCNL functional antibody

Anti-FCN2/ EBP-37/ FCNL functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FCN2/FCN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0211-Ab-1/ GM-Tg-hg-SE0211-Ab-2Anti-Human FCN2 monoclonal antibodyHuman
GM-Tg-rg-SE0211-Ab-1/ GM-Tg-rg-SE0211-Ab-2Anti-Rat FCN2 monoclonal antibodyRat
GM-Tg-mg-SE0211-Ab-1/ GM-Tg-mg-SE0211-Ab-2Anti-Mouse FCN2 monoclonal antibodyMouse
GM-Tg-cynog-SE0211-Ab-1/ GM-Tg-cynog-SE0211-Ab-2Anti-Cynomolgus/ Rhesus macaque FCN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0211-Ab-1/ GM-Tg-felg-SE0211-Ab-2Anti-Feline FCN2 monoclonal antibodyFeline
GM-Tg-cang-SE0211-Ab-1/ GM-Tg-cang-SE0211-Ab-2Anti-Canine FCN2 monoclonal antibodyCanine
GM-Tg-bovg-SE0211-Ab-1/ GM-Tg-bovg-SE0211-Ab-2Anti-Bovine FCN2 monoclonal antibodyBovine
GM-Tg-equg-SE0211-Ab-1/ GM-Tg-equg-SE0211-Ab-2Anti-Equine FCN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0211-Ab-1/ GM-Tg-hg-SE0211-Ab-2; GM-Tg-rg-SE0211-Ab-1/ GM-Tg-rg-SE0211-Ab-2;
GM-Tg-mg-SE0211-Ab-1/ GM-Tg-mg-SE0211-Ab-2; GM-Tg-cynog-SE0211-Ab-1/ GM-Tg-cynog-SE0211-Ab-2;
GM-Tg-felg-SE0211-Ab-1/ GM-Tg-felg-SE0211-Ab-2; GM-Tg-cang-SE0211-Ab-1/ GM-Tg-cang-SE0211-Ab-2;
GM-Tg-bovg-SE0211-Ab-1/ GM-Tg-bovg-SE0211-Ab-2; GM-Tg-equg-SE0211-Ab-1/ GM-Tg-equg-SE0211-Ab-2
Products NameAnti-FCN2 monoclonal antibody
Formatmab
Target NameFCN2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FCN2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0211-Ag-1Recombinant multi-species FCN2/ EBP-37/ FCNL protein
    ORF Viral VectorpGMLP004783human FCN2 Lentivirus plasmid
    ORF Viral VectorvGMLP004783human FCN2 Lentivirus particle
    ORF Viral VectorpGMLPm000560mouse Fcnb Lentivirus plasmid
    ORF Viral VectorvGMLPm000560mouse Fcnb Lentivirus particle


    Target information

    Target IDGM-SE0211
    Target NameFCN2
    Gene ID2220
    Gene Symbol and SynonymsEBP-37,FCN1,FCN2,FCNL,ficolin-2,P35
    Uniprot AccessionQ15485
    Uniprot Entry NameFCN2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000160339
    Target ClassificationN/A

    The target: FCN2, gene name: FCN2, also named as EBP-37, FCNL, P35, ficolin-2. The product of this gene belongs to the ficolin family of proteins. This family is characterized by the presence of a leader peptide, a short N-terminal segment, followed by a collagen-like region, and a C-terminal fibrinogen-like domain. This gene is predominantly expressed in the liver, and has been shown to have carbohydrate binding and opsonic activities. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.